Dr Nicholas Fuller

Commercial and Industry Research Leader and Author of Interval Weight Loss

Member of the Charles Perkins Centre

Telephone +61 2 8627 1932

Website Dr Nick Fuller

Map

Biographical details

Dr Fuller brings together a diversity of skills having held positions in both the industry and academic sectors. His current position as research program leader within the Charles Perkins Centre at the University of Sydney involves working with government and industry to identify and develop cost-effective treatments for the treatment and management of obesity and related physical and mental disorders. He has a proven track record of commercialising research in this field to improve not only the health of Australians but the rest of the globe, and continues to receive significant funding and awards for his work. He is a recognised media expert across various mediums, is the author of a book with Penguin publishing, and has published in top ranked journals in the medical field. Nick's work has resulted in policy change in the field of obesity and metabolic disease.

Research interests

Dr Fuller has worked across the academic sector for the past decade and prior to this held positions in the corporate and industry sectors. He currently leads the research stream within the Charles Perkins Centre at the University of Sydney. The research at this institute focuses on the physical and mental health disorders associated with overweight and obesity. Nick works with a range of government and industry bodies to understand and help solve the challenges they confront, and to help improve the health of Australians. This has resulted in attracting funding for the investigation of a broad range of projects including dietary & exercise programmes, complementary medicines, commercial weight loss programmes, medical devices, bariatric surgery, satiety hormones, and the economics of obesity. He has a strong passion for innovation and has been inspirational in the adoption of new technology and tools in the brand new start-of-the-art Charles Perkins Centre facility.

Nick is a consultant for industry and government organisations, as well as being a sought after public speaker for corporate and government organisations. His work has received national and international exposure and he is a regular media profile for television and radio, and traditional and online print. Nick is ranked in the top 20 scientific authors for The Conversation.

The importance of a holistic approach to weight management and associated illness is something he is particularly passionate about implementing, and dispelling the myth that one solution can fit all. Away from his work he practices what he preaches, and competes at a national level in track & field.

Current research students

Project title Research student
The efficacy of complementary medicines for prevention of type 2 diabetes mellitus Erica BESSELL
Addressing the challenges of recruiting men to a large, multi-centre diabetes prevention study Karen BRACKEN

Current projects

Working with a broad client portfolio, Dr Fuller's team provides independent clinical analysis of emerging products and technology for the treatment of obesity and associated illness and disease.

Beyond just specialising in health economics, the team provide clients with everything from concept to completion:
- Study design
- Scientific protocol writing
- Data analysis
- Publication of results in scientific journals
- Dissemination of results to the media

In the media

Dr Fuller is a recognised media profile across a variety of mediums including:

  •     Television (such as ABC, Channel 9, Channel 10)
  •     Radio (ABC, 2UE, 2GB)
  •     Print (such as Fairfax media and News Corp Australia)
  •     Online editorials (such as Medical Observer, The Conversation)

International links

Germany

(Institute of Health Economics and Health Care Management, Germany) Collaborator on a cost effectiveness analysis for an international randomised controlled trial

Germany

(University of Munich, Germany) Collaborator on an international randomised controlled trial investigating a shared care approach between general practitioners and commercial weight loss providers

United Kingdom

(Medical Research Council) Collaborator on an international trial investigating a shared care approach between general practitioners and commercial weight loss providers

Selected grants

2017

  • A double blinded, randomised controlled trial to determine a) the efficacy of FBCx (a formula based on α-cyclodextrin on weight loss, and b) the efficacy of Ginst15 (a ginseng extract formula based on Compound K) on glycaemic control; Caterson I, Fuller N; Soho Flordis International/Clinical Trial - Research Agreement.
  • Wassup? Embedded Mental Health Education; Wedgwood N, Fuller N, Burns J, Bonati M, Shaw T, Amon K; DVC Education/Small Educational Innovation Grant.

2015

  • A double blinded, randomised controlled trial to determine a) the efficacy of FBCx (a formulations containing a-cyclodextrin) on weight loss, and b) the efficacy of Ginst15 (a formulation containing compound K) on glycaemic control (Phase III) [SOHO Flord; Caterson I, Fuller N; Soho Flordis International/Clinical Trial - Research Agreement.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Fuller, N. (2017). Interval Weight Loss. Sydney: Ebury Press.

Book Chapters

  • Fuller, N., Fong, M., Lau, N. (2015). Commercial weight loss programs and their effectiveness in managing obesity. In Timothy Gill (Eds.), Managing and Preventing Obesity: Behavioural Factors and Dietary Interventions, (pp. 243-255). Cambridge, UK: Woodhead Publishing Limited. [More Information]

Journals

  • Lauche, R., Fuller, N., Cramer, H., Wardle, J., Sibbritt, D., Adams, J. (2018). Associations between complementary medicine, satisfaction with body weight and shape, and the use of methods to lose or control weight: Results of a national survey of 8009 Australian women. Complementary Therapies in Medicine, 36, 100-106. [More Information]
  • Fuller, N., Salis (nee Sainsbury), A., Caterson, I., Denyer, G., Fong, M., Gerofi, J., Leung, H., Lau, N., Williams, K., Januszewski, A., Jenkins, A., Markovic, T. (2018). Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. American Journal of Clinical Nutrition, 107(6), 921-931. [More Information]
  • Ambrosini, G., Solis-Trapala, I., Ahern, A., Fuller, N., Holzapfel, C., Hauner, H., Caterson, I., Jebb, S. (2018). Greater improvements in diet quality among overweight participants following a group-based commercial weight loss programme than those receiving support to lose weight in primary care. Nutrition Journal, 17(1), 1-11. [More Information]
  • Lauche, R., Sibbritt, D., Ostermann, T., Fuller, N., Adams, J., Cramer, H. (2017). Associations between yoga/meditation use, body satisfaction, and weight management methods: Results of a national cross-sectional survey of 8009 Australian women. Nutrition: an international journal of applied and basic nutritional science, 34, 58-64. [More Information]
  • Fuller, N., Fong, M., Gerofi, J., Ferkh, F., Leung, H., Leung, L., Zhang, S., Skilton, M., Caterson, I. (2017). Comparison of an electronic versus traditional food diary for assessing dietary intake�A validation study. Obesity Research & Clinical Practice, 11(6), 647-654. [More Information]
  • McMullan, R., Fuller, N., Caterson, I., Celermajer, D., Gordon, A., Hespe, C., Hyett, J., O'Reilly, C., Phipps, H., Skilton, M. (2017). Developmental Origins of Health and Disease: Who knows? Who cares? Journal of Paediatrics and Child Health, 53(6), 613-614. [More Information]
  • Fuller, N., Markovic, T., Salis (nee Sainsbury), A., Caterson, I. (2017). Eggs and type 2 diabetes: Current evidence suggests no cause for concern in the short-term. Nutrition Bulletin, 42(1), 6-9. [More Information]
  • Fuller, N., Salis, A., Caterson, I., Enarsson, M., Denyer, G., Manns, C., Swinbourne, J., Quinto da Luz, F., Fong, M., Markovic, T. (2017). Examining mindfulness as a predictor of weight loss � Findings from the DIABEGG study. Obesity Research & Clinical Practice, 11(1), 88-96. [More Information]
  • Fuller, N., Burns, J., Salis (nee Sainsbury), A., Horsfield, S., Quinto da Luz, F., Zhang, S., Denyer, G., Markovic, T., Caterson, I. (2017). Examining the association between depression and obesity during a weight management programme. Clinical Obesity, 7(6), 354-359. [More Information]
  • Fuller, N., Lau, N., Markovic, T., Caterson, I. (2017). Investigating general medication prescription by general practitioners during a 12-month randomized controlled weight loss trial. Clinical Obesity, 7(4), 222-230. [More Information]
  • Fuller, N., Courtney, R. (2016). A case of remission from pre-diabetes following intermittent hypoxic training. Obesity Research & Clinical Practice, 10(4), 487-491. [More Information]
  • Fuller, N., Fong, M., Gerofi, J., Leung, L., Leung, H., Denyer, G., Caterson, I. (2016). A randomized controlled trial to determine the efficacy of a high carbohydrate and high protein ready-to-eat food product for weight loss. Clinical Obesity, 6(2), 108-116. [More Information]
  • Fuller, N. (2016). In response to 'Capsaicinoids: a spicy solution to the management of obesity?'. International Journal of Obesity, 40(8), 1330-1330. [More Information]
  • Fuller, N., Salis (nee Sainsbury), A., Caterson, I., Markovic, T. (2015). Egg Consumption and Human Cardio-Metabolic Health in People with and without Diabetes. Nutrients, 7(9), 7399-7420. [More Information]
  • Walker, C., Solis-Trapala, I., Holzapfel, C., Ambrosini, G., Fuller, N., Loos, R., Hauner, H., Caterson, I., Jebb, S. (2015). Modelling the Interplay between Lifestyle Factors and Genetic Predisposition on Markers of Type 2 Diabetes Mellitus Risk. PloS One, 10(7), 1-15. [More Information]
  • Fuller, N., Caterson, I., Sainsbury, A., Denyer, G., Fong, M., Gerofi, J., Baqleh, K., Williams, K., Lau, N., Markovic, T. (2015). The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. American Journal of Clinical Nutrition, 101(4), 705-713. [More Information]
  • Fuller, N., Williams, K., Shrestha, R., Ahern, A., Holzapfel, C., Hauner, H., Jebb, S., Caterson, I. (2014). Changes in physical activity during a weight loss intervention and follow-up; a randomized controlled trial. Clinical Obesity, 4(3), 127-135. [More Information]
  • Fuller, N., Carter, H., Schofield, D., Hauner, H., Jebb, S., Colagiuri, S., Caterson, I. (2014). Cost-effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: A modelled lifetime analysis. International Journal of Obesity, 38(8), 1104-1109. [More Information]
  • Holzapfel, C., Cresswell, L., Ahern, A., Fuller, N., Eberhard, M., Stoll, J., Mander, A., Jebb, S., Caterson, I., Hauner, H. (2014). The challenge of a 2-year follow-up after intervention for weight loss in primary care. International Journal of Obesity, 38(6), 806-811. [More Information]
  • Lopez-Legarrea, P., Fuller, N., Zulet, M., Martinez, J., Caterson, I. (2014). The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pacific Journal of Clinical Nutrition, 23(3), 360-368. [More Information]
  • Fuller, N., Colagiuri, S., Schofield, D., Olson, A., Shrestha, R., Holzapfel, C., Wolfenstetter, S., Holle, R., Ahem, A., Hauner, H., Caterson, I., et al (2013). A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care - an international randomised controlled trial. International Journal of Obesity, 37(6), 828-834. [More Information]
  • Fuller, N., Pearson, S., Lau, N., Wlodarczyk, J., Halstead, M., Tee, H., Chettiar, R., Kaffes, A. (2013). An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity, 21(8), 1561-1570. [More Information]
  • Fuller, N., Lau, N., Denyer, G., Caterson, I. (2013). An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clinical Obesity, 3(6), 172-179. [More Information]
  • Fuller, N., Lau, N., Denyer, G., Caterson, I. (2012). A 12-month, randomised, controlled trial to examine the efficacy of the Korean diet in an Australian overweight and obese population - A follow up analysis. Obesity Research & Clinical Practice, 6(4), e298-e307. [More Information]
  • Fuller, N., Lau, N., Denyer, G., Simpson, A., Gerofi, J., Wu, M., Holmes, A., Markovic, T., Kang, J., Caterson, I. (2012). A 12-week, randomised, controlled trial to examine the acceptability of the Korean diet and its effectiveness on weight and metabolic parameters in an Australian overweight and obese population. Obesity Research & Clinical Practice, 6(1), e71-e83. [More Information]
  • Jebb, S., Ahern, A., Olson, A., Aston, L., Holzapfel, C., Stoll, J., Amann-Gassner, U., Simpson, A., Fuller, N., Pearson, S., Lau, N., Caterson, I., et al (2011). Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. The Lancet, 378(9801), 1485-1492. [More Information]
  • Lau, N., Fuller, N., Caterson, I. (2011). The practical value of the metabolic syndrome. Medicine Today, 12(12), 29-34.

2018

  • Lauche, R., Fuller, N., Cramer, H., Wardle, J., Sibbritt, D., Adams, J. (2018). Associations between complementary medicine, satisfaction with body weight and shape, and the use of methods to lose or control weight: Results of a national survey of 8009 Australian women. Complementary Therapies in Medicine, 36, 100-106. [More Information]
  • Fuller, N., Salis (nee Sainsbury), A., Caterson, I., Denyer, G., Fong, M., Gerofi, J., Leung, H., Lau, N., Williams, K., Januszewski, A., Jenkins, A., Markovic, T. (2018). Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. American Journal of Clinical Nutrition, 107(6), 921-931. [More Information]
  • Ambrosini, G., Solis-Trapala, I., Ahern, A., Fuller, N., Holzapfel, C., Hauner, H., Caterson, I., Jebb, S. (2018). Greater improvements in diet quality among overweight participants following a group-based commercial weight loss programme than those receiving support to lose weight in primary care. Nutrition Journal, 17(1), 1-11. [More Information]

2017

  • Lauche, R., Sibbritt, D., Ostermann, T., Fuller, N., Adams, J., Cramer, H. (2017). Associations between yoga/meditation use, body satisfaction, and weight management methods: Results of a national cross-sectional survey of 8009 Australian women. Nutrition: an international journal of applied and basic nutritional science, 34, 58-64. [More Information]
  • Fuller, N., Fong, M., Gerofi, J., Ferkh, F., Leung, H., Leung, L., Zhang, S., Skilton, M., Caterson, I. (2017). Comparison of an electronic versus traditional food diary for assessing dietary intake�A validation study. Obesity Research & Clinical Practice, 11(6), 647-654. [More Information]
  • McMullan, R., Fuller, N., Caterson, I., Celermajer, D., Gordon, A., Hespe, C., Hyett, J., O'Reilly, C., Phipps, H., Skilton, M. (2017). Developmental Origins of Health and Disease: Who knows? Who cares? Journal of Paediatrics and Child Health, 53(6), 613-614. [More Information]
  • Fuller, N., Markovic, T., Salis (nee Sainsbury), A., Caterson, I. (2017). Eggs and type 2 diabetes: Current evidence suggests no cause for concern in the short-term. Nutrition Bulletin, 42(1), 6-9. [More Information]
  • Fuller, N., Salis, A., Caterson, I., Enarsson, M., Denyer, G., Manns, C., Swinbourne, J., Quinto da Luz, F., Fong, M., Markovic, T. (2017). Examining mindfulness as a predictor of weight loss � Findings from the DIABEGG study. Obesity Research & Clinical Practice, 11(1), 88-96. [More Information]
  • Fuller, N., Burns, J., Salis (nee Sainsbury), A., Horsfield, S., Quinto da Luz, F., Zhang, S., Denyer, G., Markovic, T., Caterson, I. (2017). Examining the association between depression and obesity during a weight management programme. Clinical Obesity, 7(6), 354-359. [More Information]
  • Fuller, N. (2017). Interval Weight Loss. Sydney: Ebury Press.
  • Fuller, N., Lau, N., Markovic, T., Caterson, I. (2017). Investigating general medication prescription by general practitioners during a 12-month randomized controlled weight loss trial. Clinical Obesity, 7(4), 222-230. [More Information]

2016

  • Fuller, N., Courtney, R. (2016). A case of remission from pre-diabetes following intermittent hypoxic training. Obesity Research & Clinical Practice, 10(4), 487-491. [More Information]
  • Fuller, N., Fong, M., Gerofi, J., Leung, L., Leung, H., Denyer, G., Caterson, I. (2016). A randomized controlled trial to determine the efficacy of a high carbohydrate and high protein ready-to-eat food product for weight loss. Clinical Obesity, 6(2), 108-116. [More Information]
  • Fuller, N. (2016). In response to 'Capsaicinoids: a spicy solution to the management of obesity?'. International Journal of Obesity, 40(8), 1330-1330. [More Information]

2015

  • Fuller, N., Fong, M., Lau, N. (2015). Commercial weight loss programs and their effectiveness in managing obesity. In Timothy Gill (Eds.), Managing and Preventing Obesity: Behavioural Factors and Dietary Interventions, (pp. 243-255). Cambridge, UK: Woodhead Publishing Limited. [More Information]
  • Fuller, N., Salis (nee Sainsbury), A., Caterson, I., Markovic, T. (2015). Egg Consumption and Human Cardio-Metabolic Health in People with and without Diabetes. Nutrients, 7(9), 7399-7420. [More Information]
  • Walker, C., Solis-Trapala, I., Holzapfel, C., Ambrosini, G., Fuller, N., Loos, R., Hauner, H., Caterson, I., Jebb, S. (2015). Modelling the Interplay between Lifestyle Factors and Genetic Predisposition on Markers of Type 2 Diabetes Mellitus Risk. PloS One, 10(7), 1-15. [More Information]
  • Fuller, N., Caterson, I., Sainsbury, A., Denyer, G., Fong, M., Gerofi, J., Baqleh, K., Williams, K., Lau, N., Markovic, T. (2015). The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. American Journal of Clinical Nutrition, 101(4), 705-713. [More Information]

2014

  • Fuller, N., Williams, K., Shrestha, R., Ahern, A., Holzapfel, C., Hauner, H., Jebb, S., Caterson, I. (2014). Changes in physical activity during a weight loss intervention and follow-up; a randomized controlled trial. Clinical Obesity, 4(3), 127-135. [More Information]
  • Fuller, N., Carter, H., Schofield, D., Hauner, H., Jebb, S., Colagiuri, S., Caterson, I. (2014). Cost-effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: A modelled lifetime analysis. International Journal of Obesity, 38(8), 1104-1109. [More Information]
  • Holzapfel, C., Cresswell, L., Ahern, A., Fuller, N., Eberhard, M., Stoll, J., Mander, A., Jebb, S., Caterson, I., Hauner, H. (2014). The challenge of a 2-year follow-up after intervention for weight loss in primary care. International Journal of Obesity, 38(6), 806-811. [More Information]
  • Lopez-Legarrea, P., Fuller, N., Zulet, M., Martinez, J., Caterson, I. (2014). The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pacific Journal of Clinical Nutrition, 23(3), 360-368. [More Information]

2013

  • Fuller, N., Colagiuri, S., Schofield, D., Olson, A., Shrestha, R., Holzapfel, C., Wolfenstetter, S., Holle, R., Ahem, A., Hauner, H., Caterson, I., et al (2013). A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care - an international randomised controlled trial. International Journal of Obesity, 37(6), 828-834. [More Information]
  • Fuller, N., Pearson, S., Lau, N., Wlodarczyk, J., Halstead, M., Tee, H., Chettiar, R., Kaffes, A. (2013). An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity, 21(8), 1561-1570. [More Information]
  • Fuller, N., Lau, N., Denyer, G., Caterson, I. (2013). An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clinical Obesity, 3(6), 172-179. [More Information]

2012

  • Fuller, N., Lau, N., Denyer, G., Caterson, I. (2012). A 12-month, randomised, controlled trial to examine the efficacy of the Korean diet in an Australian overweight and obese population - A follow up analysis. Obesity Research & Clinical Practice, 6(4), e298-e307. [More Information]
  • Fuller, N., Lau, N., Denyer, G., Simpson, A., Gerofi, J., Wu, M., Holmes, A., Markovic, T., Kang, J., Caterson, I. (2012). A 12-week, randomised, controlled trial to examine the acceptability of the Korean diet and its effectiveness on weight and metabolic parameters in an Australian overweight and obese population. Obesity Research & Clinical Practice, 6(1), e71-e83. [More Information]

2011

  • Jebb, S., Ahern, A., Olson, A., Aston, L., Holzapfel, C., Stoll, J., Amann-Gassner, U., Simpson, A., Fuller, N., Pearson, S., Lau, N., Caterson, I., et al (2011). Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. The Lancet, 378(9801), 1485-1492. [More Information]
  • Lau, N., Fuller, N., Caterson, I. (2011). The practical value of the metabolic syndrome. Medicine Today, 12(12), 29-34.

To update your profile click here. For support on your academic profile contact .